Immuneel Therapeutics - Company Profile & Overview
Founded in 2018, Immuneel Therapeutics operates in Health Tech industry. Transitioning from research and development to clinical trials and commercialization, it secured funding in an extended Series ...
Funding stage:
Series B
Last funding:
07/06/2026
Total funding:
$37.13 Mn+
Revenue:
Investors
Employee count:
112
Last 90d
112
Last 90d
Web traffic:
2.32K
2.32K
Last 30d
Last 30d
Glassdoor Rating:
FAQs on Immuneel Therapeutics
Immuneel Therapeutics was founded by Kiran Mazumdar Shaw,Kush M Parmar,Siddhartha Mukherjee in 2018.
Health Tech startup Immuneel Therapeutics has raised a total funding of $37.13 million across 4 funding rounds. The last round of funding was raised on 08 June 2026. Find the details around funding rounds, participating investors, and other insights of Immuneel Therapeutics here...
Immuneel Therapeutics is a company based in Bengaluru, Karnataka, India, operating in the healthtech sector. Founded in 2018, it now employs 97 individuals. The company was established by Kiran Mazumdar Shaw,Kush M Parmar,Siddhartha Mukherjee.
Immuneel Therapeutics reported revenue of ₹9.9 Cr in FY25, an increase of 341.0% from FY24 (₹2.2 Cr).
Immuneel Therapeutics is headquartered in Bengaluru, India.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links